Skip to main content
SpringerLink
Log in

Hypertension in hemodialysis patients

  • Published:
Current Hypertension Reports Aims and scope Submit manuscript

Abstract

Hypertension is very common and often poorly controlled in patients undergoing chronic hemodialysis. While high blood pressure has been documented to adversely impact several intermediate outcomes of cardiovascular disease, whether hypertension is an independent risk factor for mortality in this population is not clear. Expansion of extracellular fluid volume is the major pathophysiologic mechanism for the development of hypertension in these patients; however, alterations in other humoral mechanisms also play a significant role. Optimization of volume status is, therefore, the cornerstone of therapy with additional use of antihypertensive medications as needed. Good quality prospective studies are urgently needed to define the measurement techniques and blood pressure goals, and to develop therapeutic strategies for more effective management of hypertension in this high-risk population.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. US Renal Data System Annual Data Report. In Bethesda: 2000.

  2. National Kidney Foundation: Dialysis outcomes quality initiative. Am J Kidney Dis 1997, 30(Suppl 2):S1-S136.

    Google Scholar 

  3. Scribner BH: Reducing mortality in dialysis patients: why does hypertension continue to be overlooked? Semin Dial 1997, 10:250.

    Google Scholar 

  4. Mailloux LU: Hypertension in the hemodialysis population. Am J Kidney Dis 1997, 29:811–812.

    PubMed  CAS  Google Scholar 

  5. Mittal SK, Kowalski E, Trenkle J, et al.: Prevalence of hypertension in a hemodialysis population. Clin Nephrol 1999, 51:77–82.

    PubMed  CAS  Google Scholar 

  6. Tozawa M, Iseki K, Fukiyama K: Hypertension in dialysis patients: a cross-sectional analysis. Nippon Jinzo Gakkai Shi 1996, 38:129–135.

    PubMed  CAS  Google Scholar 

  7. Quarello F, Piccoli GB, Magistroni P, et al.: Arterial hypertension and mortality in dialysis patients. RPDT Working Group. Contrib Nephrol 1996, 119:141–146.

    CAS  Google Scholar 

  8. Salem MM: Hypertension in the dialysis population: no easy answers. Int J Artific Organ 1996, 19:693–694.

    CAS  Google Scholar 

  9. Mailloux LU, Levey AS: Hypertension in patients with chronic renal disease. Am J Kidney Dis 1998, 32:S120-S141. This is an excellent review of the literature published as part of the National Kidney Foundation task force on cardiovascular disease in patients with renal disease.

    PubMed  CAS  Google Scholar 

  10. Cheigh JS, Milite C, Sullivan JF, et al.: Hypertension is not adequately controlled in hemodialysis patients. Am J Kidney Dis 1992, 19:453–459.

    PubMed  CAS  Google Scholar 

  11. Grekas D, Bamichas G, Bacharaki D, et al.: Hypertension in chronic hemodialysis patients: current view on pathophysiology and treatment. Clin Nephrol 2000, 53:164–168.

    PubMed  CAS  Google Scholar 

  12. Salem MM: Hypertension in the hemodialysis population: a survey of 649 patients. Am J Kidney Dis 1995, 26:461–468.

    PubMed  CAS  Google Scholar 

  13. Rahman M, Fu P, Sehgal AR, Smith MC: Interdialytic weight gain, compliance with dialysis regimen, and age are independent predictors of blood pressure in hemodialysis patients. Am J Kidney Dis 2000, 35:257–265.

    PubMed  CAS  Google Scholar 

  14. Rocco MV, Flanigan MJ, Beaver S, et al.: Report from the 1995 Core Indicators for Peritoneal Dialysis Study Group. Am J Kidney Dis 1997, 30:165–173.

    PubMed  CAS  Google Scholar 

  15. Rahman M, Dixit A, Donley V, et al.: Factors associated with inadequate blood pressure control in hypertensive hemodialysis patients. Am J Kidney Dis 1999, 33:498–506.

    PubMed  CAS  Google Scholar 

  16. Foley RN, Parfrey PS, Harnett JD, et al.: Impact of hypertension on cardiomyopathy, morbidity and mortality in end-stage renal disease. Kidney Int 1996, 49:1379–1385. This is landmark cohort study that evaluated the role of hypertension as a risk factor in cardiac dysfunction, morbidity, and mortality in ESRD patients.

    Article  PubMed  CAS  Google Scholar 

  17. Cannella G, Paoletti E, Ravera G, et al.: Inadequate diagnosis and therapy of arterial hypertension as causes of left ventricular hypertrophy in uremic dialysis patients. Kidney Int 2000, 58:260–268.

    Article  PubMed  CAS  Google Scholar 

  18. De Lima JJ, Abensur H, Bernardes-Silva H, et al.: Role of arterial hypertension in left ventricle hypertrophy in hemodialysis patients: an echocardiographic study. Cardiology 1992, 80:161–167.

    PubMed  Google Scholar 

  19. Kawamura M, Fijimoto S, Hisanaga S, et al.: Incidence, outcome, and risk factors of cerebrovascular events in patients undergoing maintenance hemodialysis. Am J Kidney Dis 1998, 31:991–996.

    PubMed  CAS  Google Scholar 

  20. De Lima JJ, Lopes HF, Grupi CJ, et al.: Blood pressure influences the occurrence of complex ventricular arrhythmia in hemodialysis patients. Hypertension 1995, 26:1200–1203.

    PubMed  Google Scholar 

  21. Complications in hemodialysis: an overview. Kidney Int 1980, 18:783–796.

  22. Malatino LS, Benedetto FA, Mallamaci F, et al.: Smoking, blood pressure and serum albumin are major determinants of carotid atherosclerosis in dialysis patients. CREED Investigators. Cardiovascular Risk Extended Evaluation in Dialysis patients. J Nephrol 1999, 12:256–260.

    PubMed  CAS  Google Scholar 

  23. Duranti E, Imperiali P, Sasdelli M: Is hypertension a mortality risk factor in dialysis? Kidney Int 1999, 55(Suppl):S173-S174.

    Google Scholar 

  24. Iseki K, Miyasato F, Tokuyama K, et al.: Low diastolic blood pressure, hypoalbuminemia, and risk of death in a cohort of chronic hemodialysis patients. Kidney Int 1997, 51:1212–1217.

    Article  PubMed  CAS  Google Scholar 

  25. Port FK, Hulbert-Shearon TE, Wolfe RA, et al.: Predialysis blood pressure and mortality risk in a national sample of maintenance hemodialysis patients. Am J Kidney Dis 1999, 33:507–517. The US Renal Data System showed the association of a low predialysis systolic blood pressure with an elevated adjusted mortality risk. No association with an elevated mortality risk could be observed for predialysis systolic hypertension.

    PubMed  CAS  Google Scholar 

  26. Zager PG, Nikolic J, Brown RH, et al.: "U" curve association of blood pressure and mortality in hemodialysis patients. Medical Directors of Dialysis Clinic, Inc. Kidney Int 1998, 54:561–569.

    Article  PubMed  CAS  Google Scholar 

  27. Mazzuchi N, Carbonell E, Fernandez-Cean J: Importance of blood pressure control in hemodialysis patient survival. Kidney Int 2000, 58:2147–2154.

    Article  PubMed  CAS  Google Scholar 

  28. Charra B, Calemard E, Ruffet M, et al.: Survival as an index of adequacy of dialysis. Kidney Int 1992, 41:1286–1291.

    PubMed  CAS  Google Scholar 

  29. Charra B, Chazot C, Jean G, Laurent G: Long, slow dialysis. Miner Electrolyte Metab 1999, 25:391–396.

    Article  PubMed  CAS  Google Scholar 

  30. Kumar A, Rahman M, Wright JT, et al.: Accuracy of blood pressure (BP) measurements in hemodialysis (HD) patients. Am J Kidney Dis 2001, 37(1):44.

    Google Scholar 

  31. Conion PJ, Walshe JJ, Heinle SK, et al.: Predialysis systolic blood pressure correlates strongly with mean 24-hour systolic blood pressure and left ventricular mass in stable hemodialysis patients. J Am Soc Nephrol 1996, 7:2658–2663.

    PubMed  CAS  Google Scholar 

  32. Kooman JP, Gladziwa U, Bocker G, et al.: Blood pressure during the interdialytic period in haemodialysis patients: estimation of representative blood pressure values. Nephrol Dial Transplant 1992, 7:917–923.

    PubMed  CAS  Google Scholar 

  33. Erturk S, Ertug AE, Ates K, et al.: Relationship of ambulatory blood pressure monitoring data to echocardiographic findings in haemodialysis patients. Nephrol Dial Transplant 1996, 11:2050–2054.

    PubMed  CAS  Google Scholar 

  34. Covic A, Goldsmith DJ: Ambulatory blood pressure monitoring in nephrology: focus on BP variability. J Nephrol 1999, 12:220–229.

    PubMed  CAS  Google Scholar 

  35. Peixoto AJ, Sica DA: Ambulatory blood pressure monitoring in end-stage renal disease. Blood Press Monit 1997, 2:275–282.

    PubMed  Google Scholar 

  36. Covic A, Goldsmith DJ, Covic M: Reduced blood pressure diurnal variability as a risk factor for progressive left ventricular dilatation in hemodialysis patients. Am J Kidney Dis 2000, 35:617–623.

    PubMed  CAS  Google Scholar 

  37. Amar J, Vernier I, Rossignol E, et al.: Nocturnal blood pressure and 24-hour pulse pressure are potent indicators of mortality in hemodialysis patients. Kidney Int 2000, 57:2485–2491.

    Article  PubMed  CAS  Google Scholar 

  38. Agarwal R: Role of home blood pressure monitoring in hemodialysis patients. Am J Kidney Dis 1999, 33:682–687.

    PubMed  CAS  Google Scholar 

  39. Martinez-Maldonado M: Hypertension in end-stage renal disease. Kidney Int Suppl 1998, 68:S67-S72.

    Article  PubMed  CAS  Google Scholar 

  40. Cannella G, Castellani A, Mioni G, et al.: Blood pressure control in end-stage renal disease in man: indirect evidence of a complex pathogenic mechanism besides renin or blood volume. Clin Sci Mol Med 1977, 52:19–21.

    PubMed  CAS  Google Scholar 

  41. Campese VM, Chanana A: Hypertension in dialysis patients. In Principles and Practice of Dialysis. Edited by Henrich WL. Baltimore: Lippincott Williams & Wilkins;1999:209–234.

    Google Scholar 

  42. Dionisio P, Valenti M, Bergia R, et al.: Influence of the hydration state on blood pressure values in a group of patients on regular maintenance hemodialysis. Blood Purif 1997, 15:25–33.

    PubMed  CAS  Google Scholar 

  43. Lins RL, Elseviers M, Rogiers P, et al.: Importance of volume factors in dialysis related hypertension. Clin Nephrol 1997, 48:29–33.

    PubMed  CAS  Google Scholar 

  44. Sherman RA, Daniel A, Cody RP: The effect of interdialytic weight gain on predialysis blood pressure. Artific Organs 1993, 17:770–774.

    CAS  Google Scholar 

  45. Luik AJ, Gladziwa U, Kooman JP, et al.: Influence of interdialytic weight gain on blood pressure in hemodialysis patients. Blood Purif 1994, 12:259–266.

    PubMed  CAS  Google Scholar 

  46. Luik AJ, van Kuijk WH, Spek J, et al.: Effects of hypervolemia on interdialytic hemodynamics and blood pressure control in hemodialysis patients. Am J Kidney Dis 1997, 30:466–474.

    PubMed  CAS  Google Scholar 

  47. Hansen J, Victor RG: Direct measurement of sympathetic activity: new insights into disordered blood pressure regulation in chronic renal failure. Curr Opin Nephrol Hypertens 1994, 3:636–643.

    Article  PubMed  CAS  Google Scholar 

  48. Ligtenberg G: Regulation of blood pressure in chronic renal failure: determinants of hypertension and dialysis-related hypotension. Neth J Med 1999, 55:13–18.

    Article  PubMed  CAS  Google Scholar 

  49. Converse RL Jr, Jacobsen TN, Toto RD, et al.: Sympathetic overactivity in patients with chronic renal failure. N Engl J Med 1992, 327:1912–1918.

    PubMed  Google Scholar 

  50. Vertes V, Cangiano JL, Berman LB, Gould A: Hypertension in end stage renal disease. N Engl J Med 1969, 280:978–981.

    PubMed  CAS  Google Scholar 

  51. Igarashi Y, Suzuki H, Imafuku T, et al.: Hypertension in patients on chronic hemodialysis: the role of the renin-angiotensin system. Jpn Circ J 1987, 51:479–484.

    PubMed  CAS  Google Scholar 

  52. Kornerup HJ: Hypertension in end-stage renal disease. The relationship between blood pressure, plasma renin, plasma renin substrate and exchangeable sodium in chronic hemodialysis patients. Acta Med Scand 1976, 200:257–261.

    PubMed  CAS  Google Scholar 

  53. Vaughan ED Jr, Carey RM, Ayers CR, Peach MJ: Hemodialysis-resistant hypertension: control with an orally active inhibitor of angiotensin-converting enzyme. J Clin Endocrinol Metab 1979, 48:869–871.

    Article  PubMed  Google Scholar 

  54. Paulitschke M, Ludat K, Riedel E, Hampl H: Long-term effects of rhEPO therapy on erythrocyte rheology in dialysis patients with different target hematocrits. Clin Nephrol 2000, 53:S36-S41.

    PubMed  CAS  Google Scholar 

  55. Yamakado M, Umezu M, Nagano M, Tagawa H: Mechanisms of hypertension induced by erythropoietin in patients on hemodialysis. Clin Invest Med 1991, 14:623–629.

    PubMed  CAS  Google Scholar 

  56. Hand MF, Haynes WG, Johnstone HA, et al.: Erythropoietin enhances vascular responsiveness to norepinephrine in renal failure. Kidney Int 1995, 48:806–813.

    Article  PubMed  CAS  Google Scholar 

  57. Heidenreich S, Rahn KH, Zidek W: Direct vasopressor effect of recombinant human erythropoietin on renal resistance vessels. Kidney Int 1991, 39:259–265.

    PubMed  CAS  Google Scholar 

  58. Tsunoda K, Abe K, Yoshinaga K: Endothelin in hemodialysis-resistant hypertension. Nephron 1991, 59:687–688.

    PubMed  CAS  Google Scholar 

  59. Bargman JM: The role of Na,K-ATPase inhibitors in hypertension and end-stage renal disease. Perit Dial Int 1997, 17:536–540.

    PubMed  CAS  Google Scholar 

  60. Shimosawa T, Kanozawa K, Nagasawa R, et al.: Adrenomedullin amidation enzyme activities in hypertensive patients. Hypertens Res 2000, 23:167–171.

    PubMed  CAS  Google Scholar 

  61. Raine AE, Bedford L, Simpson AW, et al.: Hyperparathyroidism, platelet intracellular free calcium and hypertension in chronic renal failure. Kidney Int 1993, 43:700–705.

    PubMed  CAS  Google Scholar 

  62. Schiffl H: Correlation of blood pressure in end-stage renal disease with platelet cytosolic free-calcium concentration. Klin Wochenschr 1990, 68:718–722.

    Article  PubMed  CAS  Google Scholar 

  63. Ifudu O, Matthew JJ, Macey LJ, et al.: Parathyroidectomy does not correct hypertension in patients on maintenance hemodialysis. Am J Nephrol 1998, 18:28–34.

    Article  PubMed  CAS  Google Scholar 

  64. Zoccali C, Benedetto FA, Tripepi G, et al.: Nocturnal hypoxemia, night-day arterial pressure changes and left ventricular geometry in dialysis patients. Kidney Int 1998, 53:1078–1084.

    Article  PubMed  CAS  Google Scholar 

  65. Fishbane S, Natke E, Maesaka JK: Role of volume overload in dialysis-refractory hypertension. Am J Kidney Dis 1996, 28:257–261.

    PubMed  CAS  Google Scholar 

  66. Zucchelli P, Santoro A: Dry weight in hemodialysis: Volemic control. Semin Nephrol 2001, 21:286–290.

    Article  PubMed  CAS  Google Scholar 

  67. Charra B, Laurent G, Chazot C, et al.: Clinical assessment of dry weight.Nephrol Dial Transplant 1996, 11(Suppl 2):16–19.

    PubMed  Google Scholar 

  68. Zoccali C, Dunea G: Hypertension. In Handbook of Dialysis. Edited by Daugirdas JT, Blake PS, Ing TS. Philadelphia: Lippincott Williams & Wilkins;2001:465–476

    Google Scholar 

  69. Piccoli A, Rossi B, Pillon L, Bucciante G: A new method for monitoring body fluid variation by bioimpedance analysis: the RXc graph. Kidney Int 1994, 46:534–539.

    Article  PubMed  CAS  Google Scholar 

  70. Katzarski KS, Nisell J, Randmaa I, et al.: A critical evaluation of ultrasound measurement of inferior vena cava diameter in assessing dry weight in normotensive and hypertensive hemodialysis patients. Am J Kidney Dis 1997, 30:459–465.

    PubMed  CAS  Google Scholar 

  71. Leunissen KM, Menheere PP, Cheriex EC, et al.: Plasma alpha-human atrial natriuretic peptide and volume status in chronic haemodialysis patients. Nephrol Dial Transplant 1989, 4:382–386.

    PubMed  CAS  Google Scholar 

  72. Krautzig S, Janssen U, Koch KM, et al.: Dietary salt restriction and reduction of dialysate sodium to control hypertension in maintenance haemodialysis patients. Nephrol Dial Transplant 1998, 13:552–553.

    Article  PubMed  CAS  Google Scholar 

  73. Flanigan MJ, Khairullah QT, Lim VS: Dialysate sodium delivery can alter chronic blood pressure management. Am J Kidney Dis 1997, 29:383–391.

    PubMed  CAS  Google Scholar 

  74. Woods JD, Port FK, Orzol S, et al.: Clinical and biochemical correlates of starting "daily" hemodialysis. Kidney Int 1999, 55:2467–2476.

    Article  PubMed  CAS  Google Scholar 

  75. Salem MM, Bower J: Hypertension in the hemodialysis population: any relation to one-year survival? Am J Kidney Dis 1996, 28:737–740.

    PubMed  CAS  Google Scholar 

  76. Ikeda Y, Sakemi T, Yamada M, et al.: Successful combined therapy of nifedipine and diltiazem for severe hypertension in a maintenance hemodialysis patient. Clin Nephrol 1999, 51:127–128.

    PubMed  CAS  Google Scholar 

  77. The Sixth Joint National Committee on Detection, Evaluation and Treatment of High Blood Pressure. Bethesda: National Institutes of Health National Heart, Lung and Blood Institute National High Blood Pressure Program; 1997.

  78. Aronoff GR, Berns JS, Brier ME, et al.: Drug Prescribing in Renal Failure, edn 4. Philadelphia: American College of Physicians; 1999

    Google Scholar 

  79. Brunet P, Jaber K, Berland Y, Baz M: Anaphylactoid reactions during hemodialysis and hemofiltration: role of associating AN69 membrane and angiotensin I-converting enzyme inhibitors. Am J Kidney Dis 1992, 19:444–447.

    PubMed  CAS  Google Scholar 

  80. Matsumura M, Nomura H, Koni I, Mabuchi H: Angiotensin-converting enzyme inhibitors are associated with the need for increased recombinant human erythropoietin maintenance doses in hemodialysis patients. Risks of Cardiac Disease in Dialysis Patients Study Group. Nephron 1997, 77:164–168.

    Article  PubMed  CAS  Google Scholar 

  81. Cruz DN, Perazella MA, Abu-Alfa AK, Mahnensmith RL: Angiotensin-converting enzyme inhibitor therapy in chronic hemodialysis patients: any evidence of erythropoietin resistance? Am J Kidney Dis 1996, 28:535–540.

    PubMed  CAS  Google Scholar 

  82. Cannella G, Paoletti E, Delfino R, et al.: Regression of left ventricular hypertrophy in hypertensive dialyzed uremic patients on long-term antihypertensive therapy. Kidney Int 1993, 44:881–886.

    PubMed  CAS  Google Scholar 

  83. Agarwal R: Supervised atenolol therapy in the management of hemodialysis hypertension. Kidney Int 1999, 55:1528–1535.

    Article  PubMed  CAS  Google Scholar 

  84. Box JC, Braithwaite MD, Duncan T, Lucas G: Pheochromocytoma, chronic renal insufficiency, and hemodialysis: a combination leading to a diagnostic and therapeutic dilemma. Am Surg 1997, 63:314–316.

    PubMed  CAS  Google Scholar 

  85. Saldanha LF, Weiler EW, Gonick HC: Effect of continuous ambulatory peritoneal dialysis on blood pressure control. Am J Kidney Dis 1993, 21:184–188.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Divisions of Nephrology and Hypertension, Case Western Reserve University/University Hospitals of Cleveland, 11100 Euclid Avenue, 44106, Cleveland, OH, USA

    Mahboob Rahman MD, MS

Authors
  1. Mahboob Rahman MD, MS
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Michael C. Smith MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rahman, M., Smith, M.C. Hypertension in hemodialysis patients. Current Science Inc 3, 496–502 (2001). https://doi.org/10.1007/s11906-001-0012-z

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11906-001-0012-z

Keywords

Search

Navigation